US Patent 11866742 Fusion proteins comprising enzyme replacement therapy enzymes
Patent 11866742 was granted and assigned to Denali Therapeutics on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 12 Jan, 2024
Golden AI
Edits made to:
Infobox (+77 properties)
Article (+289 characters)
US Patent 11866742 Fusion proteins comprising enzyme replacement therapy enzymes
Article
Patent abstract
Provided herein are fusion proteins that comprise an enzyme replacement therapy enzyme and an Fc region, as well as methods of using such proteins to treat a lysosomal storage disorder. Methods for transporting agents across the blood-brain barrier are also provided herein.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Adam P. Silverman0
Anastasia Henry0
Ankita Srivastava0
Cathal S. Mahon0
Julie Ullman0
Mihalis S. Kariolis0
Date of Patent
January 9, 2024
0Patent Application Number
171021380
Date Filed
November 23, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11866742 Fusion proteins comprising enzyme replacement therapy enzymes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.